RecruitingPhase 3NCT04216186
Role of Coenzyme Q in ADHD in Children
Role of Coenzyme Q in Treatment of Attention Deficit Hyperactivity Disorder in Children
Sponsor
Sherief Abd-Elsalam
Enrollment
40 participants
Start Date
Nov 1, 2018
Study Type
INTERVENTIONAL
Conditions
Summary
Role of Coenzyme Q in ADHD in Children
Eligibility
Min Age: 2 YearsMax Age: 18 Years
Inclusion Criteria1
- Patients with ADHD
Exclusion Criteria1
- Comorbidities like Autism, Anxiety, Obsessive compulsive disorder.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGAtomoxetine
Atomoxetine once daily
DRUGCoenzyme Q
Coenzyme Q once daily
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04216186
Related Trials
Trauma-adapted Yoga in Child & Adolescent Psychiatry.
NCT063307791 location
Investigating Health, Equity, and Resilience in Girls and Women With ADHD Across the Lifespan
NCT075977071 location
Intensive-neurofeedback Protocol for Children With ADHD: A Proof-of-concept Study Comparing iAPF-personalized and Standard Theta-beta-ratio Training
NCT075957832 locations
ADHD&me: Targeting Self-esteem in Youth With ADHD
NCT075041071 location
Testing a Measurement Feedback App to Improve Data Quality, Supervision & Outcomes in Behavioral Health
NCT070423471 location